pith. sign in

(2023) Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial

1 Pith paper cite this work. Polarity classification is still indexing.

1 Pith paper citing it

fields

q-bio.GN 1

years

2026 1

verdicts

ACCEPT 1

representative citing papers

citing papers explorer

Showing 1 of 1 citing paper.